Institutional Repository of Chinese Acad Sci, High Field Magnet Lab,Hefei 230031, Anhui, Peoples R China
Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl) phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor | |
Liang, Qianmao1,2; Chen, Yongfei2,3; Yu, Kailin2,4; Chen, Cheng2,3; Zhang, Shouxiang5,6; Wang, Aoli2,4; Wang, Wei2,3; Wu, Hong2,4; Liu, Xiaochuan1,2; Wang, Beilei2,3; Wang, Li2,3; Hu, Zhenquan2,3; Wang, Wenchao2,3; Ren, Tao7; Zhang, Shanchun3,8; Liu, Qingsong2,3,4,7; Yun, Cai-Hong5,6; Liu, Jing2,3 | |
2017-05-05 | |
发表期刊 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
摘要 | Currently there are several irreversible BTK inhibitors targeting Cys481 residue under preclinical or clinical development. However, most of these inhibitors also targeted other Idnases such as BMX, JAK3, and EGFR that bear the highly similar active cysteine residues. Through a structure-based drug design approach, we discovered a highly potent (IC50: 7 nM) irreversible BTK inhibitor compound 9 (CHMFL-BTK-01), which displayed a high selectivity profile in KINOMEscan (S score (35) = 0.00) among 468 kinases/mutants at the concentration of 1 mu M. Compound 9 completely abolished BMX, JAK3 and EGFR's activity. Both X-ray crystal structure and cysteine-serine mutation mediated rescue experiment confirmed 9's irreversible binding mode. 9 also potently inhibited BTK Y223 auto-phosphorylation (EC50: <30 nM), arrested cell cycle in G0/G1 phase and induced apoptosis in U2932 and Pfeiffer cells. We believe these features would make 9 a good pharmacological tool to study the BTK related pathology. (C) 2017 Elsevier Masson SAS. All rights reserved. |
文章类型 | Article |
关键词 | Btk Irreversible Inhibitor Kinase Inhibitor Structure-activity Relationship B-cell Lymphoma |
WOS标题词 | Science & Technology ; Life Sciences & Biomedicine |
DOI | 10.1016/j.ejmech.2017.03.001 |
关键词[WOS] | X-LINKED AGAMMAGLOBULINEMIA ; B-CELL ; RHEUMATOID-ARTHRITIS ; ACTIVATION ; COVALENT ; IBRUTINIB ; POTENT ; GENE ; PROLIFERATION ; EXPRESSION |
收录类别 | SCI |
语种 | 英语 |
项目资助者 | Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; Youth Foundation of National Natural Science Foundation of China(21402207) ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; National Program for Support of Top-notch Young Professionals ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; Hundred Talents Program of the Chinese Academy of Sciences ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Basic Research Program (973) of China(2012CB917202) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; National Natural Science Foundation of China(31270769) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) ; Hefei Science Center CAS(2016HSCIU007) |
WOS研究方向 | Pharmacology & Pharmacy |
WOS类目 | Chemistry, Medicinal |
WOS记录号 | WOS:000399266500008 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.hfcas.ac.cn:8080/handle/334002/33394 |
专题 | 中科院强磁场科学中心 |
作者单位 | 1.Univ Sci & Technol China, Dept Chem, Hefei 230036, Anhui, Peoples R China 2.Chinese Acad Sci, High Field Magnet Lab, Mailbox 1110,350 Shushanhu Rd, Hefei 230031, Anhui, Peoples R China 3.CHMFL HCMTC Target Therapy Joint Lab, 350 Shushanhu Rd, Hefei 230031, Anhui, Peoples R China 4.Univ Sci & Technol China, Hefei 230036, Anhui, Peoples R China 5.Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Dept Biophys,Beijing Key Lab Tumor Syst Biol, Beijing 100191, Peoples R China 6.Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Ctr Mol & Translat Med, Beijing 100191, Peoples R China 7.Chinese Acad Sci, Inst Technol Innovat, Precis Targeted Therapy Discovery Ctr, Hefei Inst Phys Sci, Hefei 230088, Anhui, Peoples R China 8.Hefei Cosource Med Technol Co LTD, 358 Ganquan Rd, Hefei 230031, Anhui, Peoples R China |
第一作者单位 | 中科院强磁场科学中心 |
推荐引用方式 GB/T 7714 | Liang, Qianmao,Chen, Yongfei,Yu, Kailin,et al. Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl) phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2017,131:107-125. |
APA | Liang, Qianmao.,Chen, Yongfei.,Yu, Kailin.,Chen, Cheng.,Zhang, Shouxiang.,...&Liu, Jing.(2017).Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl) phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,131,107-125. |
MLA | Liang, Qianmao,et al."Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl) phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 131(2017):107-125. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论